Literature DB >> 891277

Hemodynamic, ventilatory and blood gas changes during infusion of sodium nitroferricyanide (nitroprusside). Studies in patients with congestive heart failure.

S Mookherjee, J F Keighley, R A Warner, M A Bowser, A I Obeid.   

Abstract

Simultaneous hemodynamic, ventilatory, and blood gas studies were performed in 16 men with congestive heart failure before and during infusion of sodium nitroferricyanide (nitroprusside). The cardiac index increased from 2.00+/-0.16 L/min/sq m (SE) to 2.38+/-0.14 L/min/sq m, and the total pulmonary and systemic peripheral resistances fell from 928+/-123 to 494+/-57 dynes sec cm-5 and from 2,208+/-210 to 1,558+/-121 dynes sec cm-5, respectively. Both systemic and pulmonary arterial decreased during infusion of sodium nitroferricyanide, and the mixed venous oxygen pressure increased. There was no change in total or alveolar ventilation, arterial carbon dioxide tension, pH, or base excess; however, the mean arterial oxygen pressure (PaO2) decreased from 74+/-3 mm Hg to 68+/-3 mm Hg and the venous admixture effect increased from 8+/-1% to 13+/-2%. We conclude that the decrease in PaO2 during infusion of sodium nitroferricyanide resulted from a worsening of the ventilation-perfusion relationships due to increased perfusion of underventilated pulmonary units.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891277     DOI: 10.1378/chest.72.3.273

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Effects of sodium nitroprusside and urapidil on gas exchange and ventilation: perfusion ratios in patients with congestive heart failure.

Authors:  S Adnot; P Radermacher; P Andrivet; J L Dubois-Rande; A Dupeyrat; F Lemaire
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Relationship between exercise hyperpnea, hemodynamics, and blood gases before and during glyceryl trinitrate infusion in patients with exercise-induced elevation of pulmonary artery wedge pressure.

Authors:  L H Jørgensen; E Thaulow; H E Refsum
Journal:  Clin Cardiol       Date:  1997-09       Impact factor: 2.882

3.  Stability of arterial to end-tidal carbon dioxide gradients during postoperative cardiorespiratory support.

Authors:  G B Russell; J M Graybeal; J C Strout
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

4.  Controlled intravascular sodium nitroprusside treatment.

Authors: 
Journal:  Br Med J       Date:  1978-09-16

5.  Pulmonary vasodilator responses to nitroprusside and nitroglycerin in the dog.

Authors:  P J Kadowitz; P Nandiwada; C A Gruetter; L J Ignarro; A L Hyman
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

Review 6.  Pulmonary oedema: a review.

Authors:  W H Noble
Journal:  Can Anaesth Soc J       Date:  1980-05

7.  Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.

Authors:  P W Armstrong
Journal:  Can Med Assoc J       Date:  1979-10-06       Impact factor: 8.262

8.  Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease.

Authors:  D R Dantzker; J S Bower
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

Review 9.  [Captopril in congestive heart failure (author's transl)].

Authors:  G Liebau
Journal:  Klin Wochenschr       Date:  1982-02-01

Review 10.  Nitroprusside in decompensated heart failure: what should a clinician really know?

Authors:  Cristina Opasich; Giovanni Cioffi; Alessandra Gualco
Journal:  Curr Heart Fail Rep       Date:  2009-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.